Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tierney

Showing results (261-270 of 266) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 266 results.
International Studies Perspectives|June 12, 2025
Forum: Did "America First" Construct America Irrelevant?Mark A Boyer, Cameron G Thies, Louis W Pauly, et al.
Pediatrics|July 1, 1997
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndromeJ M Davis, W N Rosenfeld, S E Richter, et al.
Cancer Research|March 5, 2014
HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancerKellie S Rath, Shan K Naidu, Pushpa Lata, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2025
Clinical evaluation of patterned dried plasma spot cards to support quantification of HIV viral load and reflexive genotypingGiorgio Gianini Morbioli, Keith R Baillargeon, Monalisa N Kalimashe, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2021
Improved Inhibitory and Absorption, Distribution, Metabolism, Excretion, and Toxicology (ADMET) Properties of Blebbistatin Derivatives Indicate That Blebbistatin Scaffold Is Ideal for drug Development Targeting Myosin-2Máté Gyimesi, Anna Á Rauscher, Sharad Kumar Suthar, et al.
Cell Death and Differentiation|October 25, 2019
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteinsLeah Fitzsimmons, Rachel Cartlidge, Catherine Chang, et al.
Pageof 27

Showing results (261-270 of 266) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 266 results.
International Studies Perspectives|June 12, 2025
Forum: Did "America First" Construct America Irrelevant?Mark A Boyer, Cameron G Thies, Louis W Pauly, et al.
Pediatrics|July 1, 1997
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndromeJ M Davis, W N Rosenfeld, S E Richter, et al.
Cancer Research|March 5, 2014
HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancerKellie S Rath, Shan K Naidu, Pushpa Lata, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2025
Clinical evaluation of patterned dried plasma spot cards to support quantification of HIV viral load and reflexive genotypingGiorgio Gianini Morbioli, Keith R Baillargeon, Monalisa N Kalimashe, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2021
Improved Inhibitory and Absorption, Distribution, Metabolism, Excretion, and Toxicology (ADMET) Properties of Blebbistatin Derivatives Indicate That Blebbistatin Scaffold Is Ideal for drug Development Targeting Myosin-2Máté Gyimesi, Anna Á Rauscher, Sharad Kumar Suthar, et al.
Cell Death and Differentiation|October 25, 2019
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteinsLeah Fitzsimmons, Rachel Cartlidge, Catherine Chang, et al.
Pageof 27